Physician profile
Benjamin H Buck
NPI 1982068268
$35,260.49
in general payments reported to CMS, 2019-2025
10 companies · $20K in 2025
The $20K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $13.96 · 2024: $15K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Travel and Lodging: $5,020 · Food and Beverage: $3,742 · Education: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,875.00 |
| Travel and Lodging | $5,020.09 |
| Food and Beverage | $3,742.45 |
| Education | $509.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,942.81 | 2024-2025 | Ensite, Assurity, Tacticath |
| Boston Scientific Corporation | $11,283.36 | 2024-2025 | Emblem Mri S-Icd, Watchman Flx, Rhythmia Mapping System |
| Medtronic, INC. | $9,294.96 | 2024-2025 | Micra |
| Biosense Webster, INC. | $356.04 | 2024-2025 | Carto 3 |
| Altathera Pharmaceuticals LLC | $126.80 | 2025 | Sotalol Hydrochloride |
| Sanofi-Aventis U.S. LLC | $99.99 | 2019 | |
| Medical Device Business Services, INC. | $93.66 | 2024 | Carto 3 |
| Cordis US Corp. | $33.64 | 2025 | Mynx Control Venous |
| Convatec INC. | $15.27 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Buck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.